Cargando…
Poster: CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489242/ http://dx.doi.org/10.1016/S2152-2650(22)00854-0 |
| _version_ | 1784792835272212480 |
|---|---|
| author | Bryer, Emily Paul, Shira Chen, Jonathan Pleyer, Christopher Wiestner, Adrian Sun, Clare |
| author_facet | Bryer, Emily Paul, Shira Chen, Jonathan Pleyer, Christopher Wiestner, Adrian Sun, Clare |
| author_sort | Bryer, Emily |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9489242 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94892422022-09-21 Poster: CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL Bryer, Emily Paul, Shira Chen, Jonathan Pleyer, Christopher Wiestner, Adrian Sun, Clare Clin Lymphoma Myeloma Leuk Leukemia & Related Malignancies Elsevier Inc. 2022-10 2022-09-21 /pmc/articles/PMC9489242/ http://dx.doi.org/10.1016/S2152-2650(22)00854-0 Text en Copyright © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Leukemia & Related Malignancies Bryer, Emily Paul, Shira Chen, Jonathan Pleyer, Christopher Wiestner, Adrian Sun, Clare Poster: CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL |
| title | Poster: CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL |
| title_full | Poster: CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL |
| title_fullStr | Poster: CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL |
| title_full_unstemmed | Poster: CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL |
| title_short | Poster: CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL |
| title_sort | poster: cll-140 booster and btki interruption improve response to sars-cov-2 vaccine in patients with cll |
| topic | Leukemia & Related Malignancies |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489242/ http://dx.doi.org/10.1016/S2152-2650(22)00854-0 |
| work_keys_str_mv | AT bryeremily postercll140boosterandbtkiinterruptionimproveresponsetosarscov2vaccineinpatientswithcll AT paulshira postercll140boosterandbtkiinterruptionimproveresponsetosarscov2vaccineinpatientswithcll AT chenjonathan postercll140boosterandbtkiinterruptionimproveresponsetosarscov2vaccineinpatientswithcll AT pleyerchristopher postercll140boosterandbtkiinterruptionimproveresponsetosarscov2vaccineinpatientswithcll AT wiestneradrian postercll140boosterandbtkiinterruptionimproveresponsetosarscov2vaccineinpatientswithcll AT sunclare postercll140boosterandbtkiinterruptionimproveresponsetosarscov2vaccineinpatientswithcll |